Labiotech.eu

News and Trends 14 Apr 2023

Researchers explain how some lung tumors avoid immunotherapy

The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy. This is the main conclusion of a study recently published by a team of researchers led by Montse Sanchez-Cespedes, principal investigator of the Cancer Genetics group at the Josep Carreras […]

April 14, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 14 Apr 2023

biomodal launches new multiomics sequencing technology

biomodal, formerly known as Cambridge Epigenetix, has launched its new duet multiomics solution, which it says reveals the combinatorial power of genetic and epigenetic information from a single low volume sample. The duet multiomics solution is the world’s first single-base-resolution sequencing technology that enables the simultaneous phased reading of genetic and epigenetic information in a […]

April 14, 2023 - 3 minutesmins - By Jim Cornall

genetic sequencing DNA Human Genome Project HGP

Opinion 14 Apr 2023

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

By Dr. Radoje Drmanac, CSO of MGI and Complete Genomics Today marks the 20th anniversary of the completion of the first human genome sequence, which was mapped out on April 14, 2003. Initially a targeted effort to understand the impact of radiation on human beings, the Human Genome Project (HGP) set in motion countless advancements […]

April 14, 2023 - 6 minutesmins - By External Contributor

Podcast 14 Apr 2023

Beyond Biotech podcast 41: Sarcoidosis

This week, to coincide with World Sarcoidosis Day, we talk about sarcoidosis with Marcin Szumowski, CEO and president of the management board of Molecure. World Sarcoidosis Day As part of Sarcoidosis Awareness Month, which is observed each April, World Sarcoidosis Day is held on April 13. But what is sarcoidosis? The Foundation for Sarcoidosis Research […]

April 14, 2023

News and Trends 13 Apr 2023

Parkinson’s cure ‘inevitable’ after biomarker breakthrough

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has announced what it says is the ‘most significant breakthrough yet’ in the search for a Parkinson’s biomarker: a biological test for Parkinson’s disease. The test demonstrates high diagnostic accuracy, differentiates molecular subtypes and detects disease in individuals before cardinal movement symptoms arise. A paper on […]

April 13, 2023 - 7 minutesmins - By Jim Cornall

News and Trends 13 Apr 2023

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

Aspect Biosystems and Novo Nordisk A/S are set to collaborate on developing bioprinted tissue therapeutics to replace, repair, or supplement biological functions inside the body with the aim of delivering a new class of disease-modifying treatments for diabetes and obesity. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s background in stem cell differentiation […]

April 13, 2023 - 3 minutesmins - By Jim Cornall

Workcell with a microfluidic chip testing thousands of AI designed proteins.

News and Trends 13 Apr 2023

Adaptyv Bio launches to ‘change protein engineering’

AI tools like ChatGPT are revolutionizing how the world generates text, images and code. In a similar way, machine learning algorithms and generative AI are upending traditional processes in life sciences and collapsing time frames in drug discovery and materials development. AlphaFold by DeepMind is probably the most well-known machine learning model in this space. […]

April 13, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 13 Apr 2023

Alentis Therapeutics raises $105M for claudin platform

Alentis Therapeutics is a clinical-stage biotech developing treatments for organ fibrosis and claudin-1 (CLDN1) positive tumors. The company has announced $105 million in Series C financing. The funding round was led by Jeito Capital, Novo Holdings A/S and RA Capital Management with participation from existing investors including BB Pureos Bioventures, Bpifrance through its InnoBio 2 […]

April 13, 2023 - 3 minutesmins - By Jim Cornall

Vaccines for difficult-to-treat diseases

Best in Biotech 12 Apr 2023

6 new vaccines being developed for difficult-to-treat diseases

There are several promising new vaccine candidates being developed for complex diseases that historically have been extremely difficult to find treatments and cures for. The development of these new vaccines could eventually lead to breakthrough treatments for diseases such as Alzheimer’s disease, HIV, Parkinson’s disease, Lyme disease, and breast cancer. According to the World Health […]

April 12, 2023 - 10 minutesmins - By Willow Shah-Neville

News and Trends 12 Apr 2023

New technique developed for safer gene editing

CRISPR-Cas9 is widely used to edit the genome by studying genes of interest and modifying disease-associated genes. However, this process can be associated with potential side effects, including unwanted mutations and toxicity. Researchers at Kyushu University and Nagoya University School of Medicine in Japan have developed an optimized genome-editing method that vastly reduces mutations, opening […]

April 12, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 11 Apr 2023

PsychoGenics launches eCube AI platform for drug discovery

PsychoGenics Inc. has launched eCube, a pharmaco-electroencephalography (pharmacoEEG) platform to support phenotypic drug discovery. The company said that unlike traditional target-based drug discovery, this technique can identify novel treatments with multiple targets. Similar to the company’s AI-enabled, behavior-based platform, SmartCube, eCube harnesses machine learning to identify central nervous system (CNS) penetrant compounds and predict their […]

April 11, 2023 - 3 minutesmins - By Jim Cornall

In Depth 11 Apr 2023

Is a vaccine for Parkinson’s disease possible?

Finding a truly effective treatment for Parkinson’s disease – that goes beyond simply managing symptoms – has long been a challenging task and, to this day, there are no available therapeutic options that can effectively slow or stop the underlying disease. However, research and trials to find treatments are ongoing and, as World Parkinson’s Day […]

April 11, 2023 - 9 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Researchers explain how some lung tumors avoid immunotherapy

biomodal launches new multiomics sequencing technology

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

Beyond Biotech podcast 41: Sarcoidosis

Parkinson’s cure ‘inevitable’ after biomarker breakthrough

Aspect and Novo Nordisk working on bioprinted tissue for diabetes and obesity

Adaptyv Bio launches to ‘change protein engineering’

Alentis Therapeutics raises $105M for claudin platform

6 new vaccines being developed for difficult-to-treat diseases

New technique developed for safer gene editing

PsychoGenics launches eCube AI platform for drug discovery

Is a vaccine for Parkinson’s disease possible?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!